Extracellular vesicles as vaccine platforms: emerging opportunities for malaria

Area of Science:

• Parasitology
• Immunology
• Biotechnology

Background:

• Malaria remains a significant global health challenge due to parasite adaptability and immune evasion.
• Asymptomatic malaria infections contribute to sustained transmission and disease burden.
• Existing preventive strategies for malaria are insufficient to meet global needs.

Purpose of the Study:

• To explore the potential of engineered extracellular vesicles (EVs) as a novel vaccine strategy for malaria.
• To discuss strategies for engineering EVs for malaria vaccine development, drawing from other disease models.
• To highlight malaria-specific features that could be leveraged by EV-based vaccines.

Main Methods:

• Review of current literature on extracellular vesicle (EV) engineering for vaccine development.
• Analysis of malaria parasite characteristics relevant to vaccine design (epitope variability, immune evasion, asymptomatic forms).
• Exploration of EV properties (antigen delivery, cell fusion, immune modulation) for therapeutic potential.

Main Results:

• EVs can be engineered to deliver specific antigens and modulate immune responses effectively.
• EVs' natural cell-fusion capabilities facilitate antigen presentation and immune activation.
• The review identifies specific malaria challenges that EV-based vaccines could potentially overcome.

Conclusions:

• Engineered extracellular vesicles (EVs) show promise as a versatile platform for malaria vaccine development.
• Leveraging EV technology could provide a new avenue to combat malaria's complex transmission dynamics and immune evasion.
• Further research into EV-based strategies is warranted to address the unmet need for effective malaria prevention.